What does the evidence say about Probiotic Depression Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Probiotic Depression Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Anxiety is a prevalent non-motor symptom of Parkinson's disease (PD), yet treatment options remain limited. [Lam JST (2026); evidence level 2] - Both the probiotic (n = 30) and placebo (n = 31) groups showed significant within-group improvements on the Parkinson Anxiety Scale, with no significant between-group differences. [Lam JST (2026); evidence level 2] - 15 16 17 19 20 21 22 23 24 The emerging evidence supports that there is a bidirectional relationship between gut microbiota and depression, representing a paradigm shift in psychiatric research [,]. [Mosavat Seyed Hamdollah (2026); evidence level 2] - Animal studies have presented some compelling evidence to suggest a causal role of dysbiosis in depression-like behaviours []. [Mosavat Seyed Hamdollah (2026); evidence level 2] - MDD and SUD often co-occur, with each disorder increasing the risk of developing the other []. [Mosavat Seyed Hamdollah (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.